Evidence map›Paper›PMID 25018886›Full record

ArticleCase reports in oncological medicine2014

Isolated liver metastasis of sacrococcygeal chordoma: case report and review of the literature.

Murat Akyol, Umut Varol, Ibrahim Yildiz, Ibrahim Vedat Bayoglu, Yasar Yildiz, Lutfiye Demir, Ahmet Dirican, Alper Can, Suna Cokmert, Mine Tunakan Oztop and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncological medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Murat AkyolDepartment of Medical Oncology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, Medical Oncology Clinic, 35360 Izmir, Turkey.
Umut VarolDepartment of Medical Oncology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, Medical Oncology Clinic, 35360 Izmir, Turkey.
Ibrahim YildizDepartment of Medical Oncology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, Medical Oncology Clinic, 35360 Izmir, Turkey.
Ibrahim Vedat BayogluDepartment of Medical Oncology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, Medical Oncology Clinic, 35360 Izmir, Turkey.
Yasar YildizDepartment of Medical Oncology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, Medical Oncology Clinic, 35360 Izmir, Turkey.
Lutfiye DemirDepartment of Medical Oncology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, Medical Oncology Clinic, 35360 Izmir, Turkey.
Ahmet DiricanDepartment of Medical Oncology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, Medical Oncology Clinic, 35360 Izmir, Turkey.
Alper CanDepartment of Medical Oncology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, Medical Oncology Clinic, 35360 Izmir, Turkey.
Suna CokmertDepartment of Medical Oncology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, Medical Oncology Clinic, 35360 Izmir, Turkey.
Mine Tunakan OztopDepartment of Pathology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, 35360 Izmir, Turkey.
Ahmet AlacaciogluDepartment of Medical Oncology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, Medical Oncology Clinic, 35360 Izmir, Turkey.
Yuksel KucukzeybekDepartment of Medical Oncology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, Medical Oncology Clinic, 35360 Izmir, Turkey.
Mustafa Oktay TarhanDepartment of Medical Oncology, Izmir Kâtip Çelebi University, Ataturk Training and Research Hospital, Medical Oncology Clinic, 35360 Izmir, Turkey ; Institute of Oncology, Dokuz Eylül University, 35360 Izmir, Turkey.
Izmir Kâtip Çelebi University · TRDokuz Eylül University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chordomas are rare neoplasms arising from notochordal remnants and may develop anywhere in the body while the most common anatomic site is the sacrococcygeal area. The most effective treatment of chordoma is surgery. Chordomas rarely metastasize to lung, bone, soft tissue, liver, lymph nodes, and skin. However, there is currently no standard systemic treatment for advanced stage chordoma. Here, we reported a rare presentation of chordoma patient with liver only metastases and poor prognosis.

Identifiers

PMID25018886
PMCPMC4074971
OpenAlexW2071986082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.